AU2002328494A1 - Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients - Google Patents

Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients

Info

Publication number
AU2002328494A1
AU2002328494A1 AU2002328494A AU2002328494A AU2002328494A1 AU 2002328494 A1 AU2002328494 A1 AU 2002328494A1 AU 2002328494 A AU2002328494 A AU 2002328494A AU 2002328494 A AU2002328494 A AU 2002328494A AU 2002328494 A1 AU2002328494 A1 AU 2002328494A1
Authority
AU
Australia
Prior art keywords
inhibitor
active ingredients
drugs containing
ace
containing chymase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002328494A
Other versions
AU2002328494B2 (en
Inventor
Naoki Hase
Naoki Tsuchiya
Hidenori Urata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority claimed from PCT/JP2002/008572 external-priority patent/WO2003018061A1/en
Publication of AU2002328494A1 publication Critical patent/AU2002328494A1/en
Application granted granted Critical
Publication of AU2002328494B2 publication Critical patent/AU2002328494B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002328494A 2001-08-24 2002-08-26 Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients Ceased AU2002328494B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001254120 2001-08-24
JP2001-254120 2001-08-24
PCT/JP2002/008572 WO2003018061A1 (en) 2001-08-24 2002-08-26 Drugs containing chymase inhibitor and ace inhibitor as the active ingredients

Publications (2)

Publication Number Publication Date
AU2002328494A1 true AU2002328494A1 (en) 2003-06-05
AU2002328494B2 AU2002328494B2 (en) 2008-06-26

Family

ID=19082322

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002328494A Ceased AU2002328494B2 (en) 2001-08-24 2002-08-26 Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients

Country Status (9)

Country Link
US (2) US20040122042A1 (en)
EP (1) EP1419785A4 (en)
JP (1) JP4173098B2 (en)
KR (1) KR100902799B1 (en)
CN (2) CN101433717A (en)
AU (1) AU2002328494B2 (en)
CA (1) CA2442761A1 (en)
NZ (1) NZ528291A (en)
WO (1) WO2003018061A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004001034A1 (en) 2003-05-14 2005-03-28 Teijin Pharma Ltd CRYSTALLINE FORMS OF ACID 4- (1 - ((, ETILBENZOTIOFEN-3-IL) ME TIL) BENZIMIDAZOL-2-ILTIO) BUTANOIC; PROCEDURE FOR THE PREPARATION OF CRYSTAL FORMS; PHARMACEUTICAL COMPOSITION; AND ITS USE FOR THE TREATMENT OF INFLAMMATORY, ALLERGIC DISEASES, R
CA2536435A1 (en) * 2003-08-22 2005-03-03 Teijin Pharma Limited Drug containing chymase inhibitor as the active ingredient
JP5063348B2 (en) * 2004-08-26 2012-10-31 アクテリオン ファーマシューティカルズ リミテッド 2-sulfanyl-benzimidazol-1-yl-acetic acid derivative
US20080015240A1 (en) * 2004-11-12 2008-01-17 Mitsuru Teramoto Acid Salt of Benzimidazole Derivative and Crystal Thereof
US20100028439A1 (en) * 2005-05-23 2010-02-04 Elan Pharma International Limited Nanoparticulate stabilized anti-hypertensive compositions
JP5764064B2 (en) 2008-09-26 2015-08-12 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Novel cyclic benzimidazole derivatives useful as antidiabetic agents
AU2009307884B2 (en) 2008-10-22 2014-07-31 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
EP2352374B1 (en) * 2008-10-29 2014-09-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CN102271509A (en) 2008-10-31 2011-12-07 默沙东公司 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
EP2391624B1 (en) 2009-01-30 2013-01-16 Boehringer Ingelheim International GmbH Azaquinazolinediones useful as chymase inhibitors
CA2786314A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
MY159058A (en) 2011-02-25 2016-12-15 Merck Sharp & Dohme Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agent
MX2015001500A (en) 2012-08-02 2015-04-08 Merck Sharp & Dohme Antidiabetic tricyclic compounds.
WO2014031465A1 (en) 2012-08-22 2014-02-27 Merck Sharp & Dohme Corp. Novel azabenzimidazole tetrahydropyran derivatives
KR20150045436A (en) 2012-08-22 2015-04-28 머크 샤프 앤드 돔 코포레이션 Novel azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
EP2906040B1 (en) 2012-08-22 2021-02-17 Merck Sharp & Dohme Corp. Novel benzimidazole tetrahydropyran derivatives
EP2888007B1 (en) 2012-08-22 2019-09-18 Merck Sharp & Dohme Corp. Benzimidazole tetrahydrofuran derivatives useful as amp-activated protein kinase activators
WO2014031468A1 (en) 2012-08-22 2014-02-27 Merck Sharp & Dohme Corp. Novel benzimidazole hexahydrofuro[3,2-b]furan derivatives
US9868733B2 (en) 2012-08-22 2018-01-16 Merck Sharp & Dohme Corp. Azabenzimidazole tetrahydrofuran derivatives
EP2970119B1 (en) 2013-03-14 2021-11-03 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
WO2014151367A1 (en) 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv 1,2,5-substituted benzimidazoles as flap modulators
US9695149B2 (en) 2013-03-15 2017-07-04 Janssen Pharmaceutica Nv 1,2,6-substituted benzimidazoles as flap modulators
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
EP3068768B1 (en) 2013-11-15 2019-07-31 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2015089809A1 (en) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Antidiabetic substituted heteroaryl compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5617073B2 (en) * 1971-10-28 1981-04-20
GB1566264A (en) * 1976-04-23 1980-04-30 Whatman Reeve Angel Ltd Inside-to-outside flow filter tube and method of manufacturing same
DE2648411C2 (en) * 1976-10-26 1984-05-17 Mtu Motoren- Und Turbinen-Union Friedrichshafen Gmbh, 7990 Friedrichshafen Multi-cylinder diesel internal combustion engine
US4312308A (en) * 1980-02-21 1982-01-26 Slattery Gordon C Compression relief system for internal combustion engine
US5128339A (en) * 1990-11-01 1992-07-07 Sterling Winthrop Inc. Proteolytic enzyme inhibition method
US5128359A (en) * 1990-02-16 1992-07-07 Laboratoires Upsa Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation
FR2658511B1 (en) * 1990-02-16 1992-06-19 Union Pharma Scient Appl NOVEL BENZIMIDAZOLE AND AZABENZIMIDAZOLE DERIVATIVES, THROMBOXANE RECEPTOR ANTAGONISTS; THEIR PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
WO1997011941A1 (en) * 1995-09-28 1997-04-03 Suntory Limited Quinazoline derivatives and use thereof
CN1169791C (en) * 1996-09-06 2004-10-06 日本化药株式会社 Novel acetamide derivatives and protease inhibitors
US6080738A (en) * 1996-10-25 2000-06-27 Yoshitomi Pharmaceuticals Industries, Ltd. Heterocyclic amide compounds and medicinal uses thereof
US20040010004A1 (en) * 2000-01-17 2004-01-15 Naoki Tsuchiya Benzimidazole derivatives
AU4654199A (en) * 1998-07-23 2000-02-14 Shionogi & Co., Ltd. Monocyclic beta-lactam compounds and chymase inhibitors containing the same
EP1136488A4 (en) * 1998-12-01 2002-06-12 Meiji Seika Kaisha Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
KR100763779B1 (en) * 2000-01-17 2007-10-05 데이진 가부시키가이샤 Benzimidazole derivatives
AU783839B2 (en) * 2000-01-17 2005-12-15 Teijin Limited Human chymase inhibitors
HUP0201284A3 (en) * 2000-02-22 2003-02-28 Daiichi Asubio Pharma Co Ltd Preventive or therapeutic drugs for fibrosis containing quinazolindione derivative chymase inhibitors as the active ingredient
GB0021315D0 (en) * 2000-08-30 2000-10-18 Dainippon Pharmaceutical Co Heterocyclic compounds and intermediates thereof

Similar Documents

Publication Publication Date Title
AU2002328494A1 (en) Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients
EP1419785A4 (en) Drugs containing chymase inhibitor and ace inhibitor as the active ingredients
IL158076A0 (en) Benzamidine derivatives and pharmaceutical compositions containing the same
AU2002253619A1 (en) Heterocyclic compound and antitumor agent containing the same active ingredients
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
IL157731A0 (en) Caboxylic acid derivatives and pharmaceutical compositions containing the same
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
AU2003257666A1 (en) COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
AU2002338806A1 (en) Pharmaceutical combinations of pde-v inhibitors and other agents
AU2002355012A1 (en) Microcapsules and oral compositions containing the same
HUP0104768A3 (en) 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
AU2002257582A1 (en) Pharmaceutical formulation
IL157908A0 (en) Phthalazinone derivatives and pharmaceutical compositions containing the same
AU2001234114A1 (en) Drugs containing combined active ingredients
AU2002342907A1 (en) Gel capsules containing active ingredients and use thereof
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
IL156577A0 (en) Selective cathepsin s inhibitors and pharmaceutical compositions containing the same